Examining Vitamin D Pharmacokinetics in Children With Asthma, Obesity
Drug Topics
OCTOBER 9, 2023
Although vitamin D supplementation is a low-cost treatment option, the optimal dosing strategy is currently unknown.
Mon.Oct 09, 2023
281 
A biotech ‘tuning’ the genome for a potentially safer gene therapy
PharmaVoice
OCTOBER 9, 2023
Tune Therapeutics is hoping to overcome the pitfalls of CRISPR-style treatments with epigenetic editing.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Pediatric T1D Management Adherence System Evaluated
Drug Topics
OCTOBER 9, 2023
Technology may not help teens with the emotional and physical weight of managing the disease, study results show.
Esketamine in Combination with Oral Antidepressant Could Aid Treatment-Resistant Depression
Pharmacy Times
OCTOBER 9, 2023
Individuals treated with esketamine were more likely to reach remission and remain relapse-free at 8 weeks of treatment.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
HLTH23: Experts debate the flaws, future of Medicare Advantage
Fierce Healthcare
OCTOBER 9, 2023
LAS VEGAS—Medicare Advantage (MA) has only grown over the last decade, and, in tandem, voices criticizing the program have gotten louder. | LAS VEGAS—Medicare Advantage has only grown over the last decade, and, in tandem, voices criticizing the program have gotten louder.
Survey Finds Lack of Parental Awareness of Meningitis Risk in Children
Pharmacy Times
OCTOBER 9, 2023
Parents are not fully educated on the risk of meningitis infection and preventive efforts for their children.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Gates Foundation spends $40M to boost mRNA vaccine production in Africa and beyond
Fierce Pharma
OCTOBER 9, 2023
Following similar initiatives to bolster mRNA vaccine production and access in Africa, the Bill & Melinda Gates Foundation is providing new funding to a clutch of drugmakers. | Following similar initiatives to bolster mRNA vaccine production and access in Africa, the Bill & Melinda Gates Foundation is providing new funding to a clutch of drugmakers.
Expert: The Impact Pharmacists Provide to Expanded Scope and Care to Patients
Pharmacy Times
OCTOBER 9, 2023
Cheri Schmit, RPh, Senior Manager of clinical Solutions at Cardinal Health, discusses the role of the pharmacists, how the pharmacy profession has changed, and what is to come in the field.
HLTH23: Clear partners with Verato, b.well to 'ditch the clipboard' and scale up digital identity tech in healthcare
Fierce Healthcare
OCTOBER 9, 2023
LAS VEGAS—Despite all the digital innovation in healthcare, a visit to the doctor's office often entails filling out forms on a clipboard and repetitive paperwork. | Despite all the digital innovation in healthcare, a visit to the doctor's office often entails filling out forms on a clipboard and repetitive paperwork. Clear, a company well recognized for its biometric identity verification used in airports, wants to fix these pain points.
Use of Antidepressants in Older Adults Linked to Driving Impairment on a Road Test
Pharmacy Times
OCTOBER 9, 2023
Use of antidepressants and other classes of prescription drugs can increase the risk of driving impairment compared to nonuse, so clinicians and pharmacists should review these risks with older adults.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The PharmaVoice 100: Tech wizards
PharmaVoice
OCTOBER 9, 2023
The leaders paving the way to pharma’s future with state-of-the-art digital solutions.
Pharmacy Focus: Student Edition - Accelerating Success: Western University of Health Sciences' 3.5-Year Program
Pharmacy Times
OCTOBER 9, 2023
Tune in to this episode of Pharmacy Focus: Student Edition to discover how innovative programs like Western University's 3.5-year pharmacy program are shaping the future of pharmacy education.
STAT+: Bristol ‘take-under’ of Mirati is not so great for biotech, but company’s new cancer target has potential
STAT
OCTOBER 9, 2023
Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics: A take-under deal feels meh for biotech sector sentiment. Bristol is paying $58 per share in cash for Mirati, which closed Friday at $60. Granted, Mirati was trading in the $30 range in September, so from there, the roughly 50% premium isn’t terrible. But as Mizuho strategist Jared Holz pointed out, investors would liked to have seen Mirati go for $75-$100 per share.
HLTH23: Highmark taps Spring Health to expand behavioral health access
Fierce Healthcare
OCTOBER 9, 2023
LAS VEGAS — Highmark Health is joining forces with Spring Health to expand behavioral access for a wide swath of its members. | LAS VEGAS — Highmark Health is joining forces with Spring Health to expand behavioral access for a wide swath of its members.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: FDA rejects Alnylam’s heart disease treatment over insufficient data
STAT
OCTOBER 9, 2023
The Food and Drug Administration rejected an Alnylam Pharmaceuticals’ therapy for an increasingly prevalent heart disease, the company said Monday, citing insufficient evidence that the treatment meaningfully improved patients’ lives. Alnylam will no longer seek approval of its drug, an intravenous medicine sold as Onpattro, for people with ATTR-CM, a progressive disease that leads to heart failure if left untreated.
Cedars-Sinai, K Health launch AI-driven virtual care app for new, existing patients in CA
Fierce Healthcare
OCTOBER 9, 2023
As more patients seek tech-enabled care in the palm of their hand, providers are increasingly looking to expand their slate of virtual care offerings. | The app will make virtual care providers available around the clock for urgent issues and same-day appointments for primary care with the goal of reducing wait times for patients. All insurance types that Cedars-Sinai takes will be accepted.
Alongside diagnosis: AI’s role in shaping health transformation outcomes
pharmaphorum
OCTOBER 9, 2023
Alongside diagnosis: AI’s role in shaping health transformation outcomes Mike.
Boulder Care meets all quality metrics in first Medicaid pay-for-performance contract
Fierce Healthcare
OCTOBER 9, 2023
Boulder Care, a telehealth provider for substance use disorder, has met all of its performance quality measures in a value-based payment arrangement with a managed Medicaid insurer in Oregon. | The contract with Umpqua Health Alliance links reimbursement to a set of patient outcomes. Boulder agreed to put a portion of its reimbursement for medical services at risk until quality performance metrics were achieved.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Curio DTx hits mark in postpartum depression trial
pharmaphorum
OCTOBER 9, 2023
Curio DTx hits mark in postpartum depression trial Phil.
COVID-19 shined a spotlight on food insecurity. Here's how payers are tackling the issue
Fierce Healthcare
OCTOBER 9, 2023
The COVID-19 pandemic underscored just how many food deserts dot the nation and how poor nutrition often lays the foundation for poor health.
STAT+: A Q&A with the global head of Boehringer Ingelheim’s innovation unit
STAT
OCTOBER 9, 2023
LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline. There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.
HLTH23: VC firm General Catalyst launches new company, plans to buy a health system
Fierce Healthcare
OCTOBER 9, 2023
LAS VEGAS—Venture capital firm General Catalyst unveiled a new company Sunday designed to provide advisory services to health systems while also eyeing a big acquisition by next year. | Venture capital firm General Catalyst unveiled a new company Sunday designed to provide advisory services to health systems while also eyeing a big acquisition by next year.
HRG’s five notable products from September
Drug Store News
OCTOBER 9, 2023
HRG reviewed 34 products in the health category, 44 items in the wellness sector and 22 items in the beauty aisle to see which ones stood out as Products to Watch.
Reports: Walgreens workers staging walkouts starting today
Fierce Healthcare
OCTOBER 9, 2023
Walgreens workers are expressing their dissatisfaction at current working conditions, as reports say pharmacy workers are planning a walkout from Oct. 9 to Oct. 11. | Walgreens pharmacy workers at some locations across the country appear to be leaving work for several days. Posts on social media platforms indicate they are protesting unfair working conditions.
Novel anti-epileptic drug demonstrates efficacy
European Pharmaceutical Review
OCTOBER 9, 2023
A new drug, part of a class of chemicals called potassium-channel openers, has demonstrated potential in offering relief to patients with focal epilepsy. Key data from a clinical trial, published in a report in JAMA Neurology, has revealed that adding the drug XEN1101 to a patient’s current antiseizure treatments saw a 33 percent to 53 percent drop in monthly seizures, depending on dose.
GSK and Zhifei sign deal for shingles vaccine in China
Pharmaceutical Technology
OCTOBER 9, 2023
GSK and Chongqing Zhifei have signed an exclusive agreement for co-promoting the former’s shingles vaccine, Shingrix, in China.
BMS swoops on Mirati with $5.8bn takeover offer
pharmaphorum
OCTOBER 9, 2023
BMS swoops on Mirati with $5.8bn takeover offer Phil.
How to Use BoardVitals to Prepare for the Longitudinal Knowledge Assessment
Board Vitals - Pharmacist
OCTOBER 9, 2023
Several certifying boards, including the ABIM, have rolled out a new way for practitioners to maintain their certification. In addition to the traditional 10-year maintenance of certification (MOC) exam, the 5-year Longitudinal Knowledge Assessment (LKA) is available for many specialties. Despite its open-book format, the LKA should not be taken lightly.
Scotland first in Europe to back MSD drug for VHL tumours
pharmaphorum
OCTOBER 9, 2023
Scotland first in Europe to back MSD drug for VHL tumours Phil.
Bristol Myers Squibb agrees nearly $6bn oncology merger
European Pharmaceutical Review
OCTOBER 9, 2023
Bristol Myers Squibb ( BMS ) has agreed to acquire Mirati Therapeutics for a total of $4.8 billion. This merger deal entitles BMS to add KRAZATI (adagrasib), a best-in-class KRAS G12C inhibitor to its portfolio. The medicine is approved in the US for advanced KRAS G12C -mutated non-small cell lung cancer (NSCLC) in patients who have received at least one prior systemic treatment.
Amgen gets Horizon acquisition over the line
pharmaphorum
OCTOBER 9, 2023
Amgen gets Horizon acquisition over the line Phil.
Former Shipt exec to lead Walmart’s GoLocal delivery service
Drug Store News
OCTOBER 9, 2023
Rina Hurts has been named vice president of Walmart GoLocal, arriving from Target-owned delivery company Shipt, where she served as chief business officer since April 2020.
GSK to lean on Zhifei for Shingrix and maybe Arexvy in China
pharmaphorum
OCTOBER 9, 2023
GSK to lean on Zhifei for Shingrix and maybe Arexvy in China Phil.
Let's personalize your content